This result agrees with a recent study in patients with lung cancer, which demonstrated the presence of PAPP-A2 in cancer tissue, showed elevated circulating PAPP-A2 levels, and established an association between PAPP-A2 and all-cause mortality [13]. Here, PAPPA2 is linked to lung cancer.